UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K Commission file number: 001-33626 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 98-0533350 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Canon's Court 22 Victoria Street Hamilton HM 12 Bermuda (441) 298-3300 Securities registered pursuant to Section 12(b) of the Act: | | Trading | Name of each exchange on which | | --- | --- | --- | | Title ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style S ...

Core Insights - Nalanda India Equity Fund Ltd increased its holding in Genpact by 1,015,556 shares, valued at approximately $43.92 million, reflecting a bullish outlook on the stock [2][7] - Genpact's share price was $39.18 as of February 18, 2026, down 27.3% over the past year, underperforming the S&P 500 by 39.53 percentage points [3][4] - The company reported a revenue of $5.08 billion and a net income of $552.49 million for the trailing twelve months [4] Company Overview - Genpact is a global provider of IT and business process outsourcing services, focusing on large enterprise customers across various industries [6][8] - The company leverages digital solutions and process expertise to enhance operational efficiency and transformation for its clients [6] - Genpact serves sectors including banking, capital markets, insurance, consumer goods, healthcare, manufacturing, and high-tech industries [8] Financial Performance - Genpact's sales for 2025 were $5.1 billion, representing a 7% year-over-year increase, with expectations for another 7% growth in 2026 [9] - The company's price-to-earnings ratio is currently at 12, the lowest in a year, indicating a potentially attractive buying opportunity [10]

Core Insights - Genpact Limited is demonstrating strong execution against its strategic ambitions, with recent fiscal year results affirming confidence in the business [1] Company Performance - The company has shown a narrative shift that required patience to fully appreciate [1] Analyst Background - The analyst has a background in petroleum and gas engineering and has transitioned into finance, focusing on tech, infrastructure, and internet services [1] - The analyst holds FMVA® and BIDA® certifications and emphasizes the importance of strong fundamentals paired with growth potential [1]

Core Viewpoint - Repsol's fourth-quarter results introduced a new reporting model aimed at better representing the significance of minority shareholders and joint ventures [1] Group 1 - The new reporting model reflects the company's strategy to enhance transparency and align with the interests of minority shareholders [1] - This change is part of Repsol's broader efforts to adapt to evolving market conditions and stakeholder expectations [1]

Core Viewpoint - Pernod Ricard is focusing on cost-control measures due to weakening sales and rising costs impacting the distiller's earnings [1] Group 1: Company Performance - The company has reported a decline in sales, which has affected its overall earnings [1] - Rising costs are contributing to the pressure on the company's profitability [1] Group 2: Strategic Focus - The company is prioritizing cost-control strategies to mitigate the impact of declining sales and increasing expenses [1]

Group 1 - Airbus supports a "two-fighter solution" for the FCAS fighter program if requested by governments [1] - The comments were made by Airbus CEO Guillaume Faury during a results presentation [1] - The support comes amid a dispute between Airbus and French partner Dassault Aviation over leadership of the core warplane component [1]

Core Viewpoint - Genpact Limited (G) presents an interesting balance of risk and potential return for investors, indicating a favorable investment opportunity [1] Company Analysis - The company is recognized for its ability to provide value to investors through its shares, suggesting a positive outlook on its financial performance [1] Analyst Background - The analyst has extensive experience in the investment sector, with a focus on equity analysis across various industries, which adds credibility to the insights provided [1]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill this potential is challenging [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Genpact (G) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly attractive [3] - Genpact has a historical EPS growth rate of 11.3%, with projected EPS growth of 9% this year, surpassing the industry average of 8.7% [4] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for growth stocks, indicating efficiency in generating sales [5] - Genpact's S/TA ratio is 0.95, outperforming the industry average of 0.9, indicating higher efficiency [5] Group 4: Sales Growth - Sales growth is another key indicator, with Genpact expected to achieve a sales growth of 6.5% this year, compared to the industry average of 6.2% [6] Group 5: Earnings Estimate Revisions - Trends in earnings estimate revisions correlate strongly with near-term stock price movements, making them a valuable metric [7] - Genpact has seen upward revisions in current-year earnings estimates, with the Zacks Consensus Estimate increasing by 2.9% over the past month [8] Group 6: Overall Assessment - Genpact holds a Zacks Rank of 2 and a Growth Score of B, indicating it is a potential outperformer and a solid choice for growth investors [10]

Core Viewpoint - Genpact (G) has experienced significant selling pressure, resulting in a 21.6% decline over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a widely used technical indicator that helps identify whether a stock is oversold, with readings below 30 typically indicating oversold conditions [2]. - Genpact's current RSI reading of 26.62 suggests that the heavy selling may be exhausting, indicating a possible rebound as the stock seeks to return to its previous equilibrium of supply and demand [5]. Group 2: Fundamental Analysis - There is a strong consensus among sell-side analysts to raise earnings estimates for Genpact, with a 2.9% increase in the consensus EPS estimate over the last 30 days, which often correlates with price appreciation in the near term [7]. - Genpact holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].